Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid

The Journal of Pediatrics - Tập 137 Số 6 - Trang 865-870 - 2000
Thomas G. Boyce1,2,3, Beverly G. Mellen1,2,3, Edward F. Mitchel1,2,3, Peter F. Wright1,2,3, Marie R. Griffin1,2,3
1Departments of Pediatric and Adolescent Medicine and Internal Medicine, Mayo Clinic and Mayo Medical School, Rochester, Minnesota
2the Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
3the Departments of Preventive Medicine and Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee

Tóm tắt

Từ khóa


Tài liệu tham khảo

Institute of Medicine, 1985, Prospects for immunizing against respiratory syncytial virus, Vol 1, 397

Shay, 1999, Bronchiolitis-associated hospitalizations among US children, 1980-1996, JAMA, 282, 1440, 10.1001/jama.282.15.1440

The PREVENT Study Group, 1997, Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis, Pediatrics, 99, 93, 10.1542/peds.99.1.93

The IMpact-RSV Study Group, 1998, Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants, Pediatrics, 102, 531, 10.1542/peds.102.3.531

American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn, 1998, Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV, Pediatrics, 102, 1211, 10.1542/peds.102.5.1211

Neuzil, 2000, The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children, N Engl J Med, 342, 225, 10.1056/NEJM200001273420401

Ray, 1997, Effect of Medicaid expansions on preterm birth, Am J Prev Med, 13, 292, 10.1016/S0749-3797(18)30178-8

Groothuis, 1995, Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG), Pediatrics, 95, 463

Groothuis, 1993, Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children, N Engl J Med, 329, 1524, 10.1056/NEJM199311183292102

Simoes, 1998, Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease, J Pediatr, 133, 492, 10.1016/S0022-3476(98)70056-3

Joffe, 1999, Rehospitalization for respiratory syncytial virus among premature infants, Pediatrics, 104, 894, 10.1542/peds.104.4.894

1978, Br Med J, 2, 796, 10.1136/bmj.2.6140.796

Glezen, 1981, Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level, J Pediatr, 98, 708, 10.1016/S0022-3476(81)80829-3

Ray, 1998, Perinatal outcomes following implementation of TennCare, JAMA, 279, 314, 10.1001/jama.279.4.314

Reed, 1997, Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old, J Infect Dis, 175, 807, 10.1086/513975